Schott recently announced that it has completed the next expansion stage at its pharmaceutical glass tubing site in Jinyun, China. The company completed construction at the site in just 15 months despite the COVID-19 pandemic, with production starting in November 2020. The plant is meant to create a solid production base for high-quality borosilicate glass…
China rebuffs WHO’s plan to continue investigating origins of COVID-19
The possibility that SARS-CoV-2 resulted from a laboratory accident has gained a degree of plausibility among several world leaders. But China has rejected calls for further investigation into the matter, saying such allegations disregard “common sense,” as Zeng Yixin, vice-minister of the National Health Commission (NHC), said at a press briefing. White House press secretary…
Thermo Fisher Scientific and Innoforce team up on pharma facility in China
Thermo Fisher Scientific Inc. (NYSE:TMO) and Innoforce have agreed to set up a new pharma services facility in Hangzhou, China for biologics and drug development and manufacturing. Innoforce is a Hangzhou, China-based contract development and manufacturing company. The two companies expect to complete the facility in 2022. The site will become part of Thermo Fisher’s…
Coronavirus highlights U.S. reliance on drugs, medical products made in China
The coronavirus pandemic has cast a spotlight on U.S. reliance on pharmaceuticals made in China, with the Trump administration reportedly considering actions to increase demand for American-made drugs and medical products. The executive order in coming days would likely close loopholes that allow the federal government to buy foreign-made pharmaceutics and medical devices, The New…